β-Lactamase-IN-4

• UNSPSC Description:

  β-Lactamase-IN-4 is a β-lactamase inhibitor extracted from patent WO2013149121A1, compound 708. β-Lactamase-IN-4 can be used for the research of bacterial infections[1].

• Target Antigen:

  Bacterial; Beta-lactamase

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/β-lactamase-in-4.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1[N@]2[C@@](C3=NN=C(C4CNC4)O3)([H])CC[C@@H](N1OS(=O)(O)=O)C2

• Molecular Weight:

  345.33

• References & Citations:

  [1]Gu YG, et, al. 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors. WO2013149121A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1463520-91-3